Last edition
News about "severe alopecia areata"
Sun Pharma Presents LEQSELVITM Data at 2024 Fall Clinical Dermatology Conference
LEQSELVI data presented at Fall Clinical includes pooled long-term results from open-label extension (OLE) studies showing ongoing and clinically meaningful improvements in scalp hair regrowth in adults with AA taking LEQSELVI for up to 68 weeks.
Severe Alopecia Areata | 28/10/2024 | By Aishwarya | 101
Sun Pharma Gets US FDA Approval for LEQSELVI for Treatment of Severe Alopecia Areata
Sun Pharmaceutical Industries Ltd. has announced that the US Food and Drug Administration (FDA) has approved LEQSELVI (deuruxolitinib) 8 mg tablets for the treatment of adults with severe alopecia areata.
Severe Alopecia Areata | 26/07/2024 | By Aishwarya | 561
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy